Skip to content
cCORE MBSMedical Billing Solution

Rheumatology billing

Protect high-dollar biologic claims and secure complex autoimmune reimbursements.

Rheumatology is one of the highest-risk billing environments in medicine — driven by expensive buy-and-bill biologics, multi-hour infusion coding and high-complexity leveling. We ensure your drug units are perfectly calculated, medical necessity rules are satisfied, and high-dollar claims are paid without delay.

Services we provide for rheumatology practices

Specialty-trained coders and billers who know your workflows, payers and compliance requirements inside out.

  • High-complexity rheumatology consultation billing
  • Biologic infusion & IV therapy claims management
  • Joint aspiration & injection billing
  • Musculoskeletal ultrasound & DEXA scan billing
  • Specialty pharmacy & buy-and-bill tracking
  • Biologic prior authorization & step-therapy management
  • Drug wastage (JW & JZ) compliance auditing
  • Co-pay assistance & foundation fund tracking

Codes we manage every day

A representative sample of the CPT, ICD-10 and modifier expertise our team applies to rheumatology claims.

Common CPT codes

  • 96413, 96415Chemotherapy IV infusion (initial/add'l)
  • 96365, 96366Therapeutic IV infusion
  • 96372Subcutaneous / IM injection
  • 20610, 20611Major joint aspiration/injection
  • 77080DEXA bone density study
  • J1745Injection, infliximab (Remicade)
  • J9312Injection, rituximab (Rituxan)

Common diagnosis codes

  • M05.79 / M06.9Rheumatoid arthritis
  • M32.9Systemic lupus erythematosus
  • M45.9Ankylosing spondylitis
  • M10.9Gout, unspecified
  • M81.0Postmenopausal osteoporosis

Modifiers we manage

  • JW / JZDrug wasted / zero waste (single-dose vials)
  • 25Separate E/M on injection day
  • 50Bilateral joint injection
  • 26 / TCProfessional / technical for DEXA

Common billing challenges we solve

  • High-dollar buy-and-bill denials from unit mismatches
  • JW/JZ modifier omissions triggering compliance audits
  • Infusion vs. hydration bundling downcoding
  • Step-therapy 'fail first' tracking for biologic approvals
  • DEXA frequency-limit denials (24-month rule)

Payers we work with

  • Medicare & Medicare Advantage (Part B vs. Part D)
  • Medicaid & Managed Medicaid
  • Commercial carriers (BCBS, UHC, Aetna, Cigna, Humana)
  • Manufacturer co-pay cards & assistance programs
  • HSA / FSA

Why rheumatology practices choose Core MBS

Biologic and specialty-medication experts
Flawless drug-unit calculations avoid whole-claim rejections
Proactive payer-policy monitoring on preferred biologics
Buy-and-bill inventory margin audits

Let's get your revenue cycle healthy.

Send us a note for a free, no-obligation billing review — we'll show you exactly where revenue is leaking and how we'd fix it.